IP Library Assignment 020206/0703
Patent Assignment
Reel/Frame 020206/0703

Change of Name

Recorded: 2007-12-03 Pages: 3
Assignor
QUARK BIOTECH, INC.
Executed: 2007-06-01
Assignee
QUARK PHARMACUTICALS, INC.
6501 DUMBARTON CIRCLE, FREMONT, CALIFORNIA, 94555
Covered Properties (38)
Gene Identification Method
Patent: 6,057,111 →
Application: 09/284,782 →
Isolation of Cdna Encoding for Secreted or Membranal Proteins
Patent: 6,403,316 →
Application: 09/534,661 →
Methods of Diagnosing Bladder Cancer
Patent: 6,998,232 →
Application: 09/825,682 →
Genes Involved in Stroke Response and/or Regulated by FK506, Proteins Encoded Thereby, and Methods of Use
Patent: 6,833,237 →
Application: 10/021,338 →
Inhibitors of Spermidine Synthase for the Treatment of Osteoarthritis and Cartilage Rehabilitation
Patent: 6,696,454 →
Application: 10/023,038 →
Publication: US 2002/0160978
Use of Axl receptor for diagnosis and treatment of renal disease
Application: 10/365,135 →
Publication: US 2003/0157573
Methods of Preventing or Treating Brain Ischemia or Brain Injury
Patent: 7,202,211 →
Application: 10/371,725 →
Publication: US 2003/0219430
Use of the endo-180 gene and polypeptide for diagnosis and treatment
Application: 10/557,089 →
Publication: US 2007/0072244
Methods for Cloning Nucleic Acids in a Desired Orientation
Application: 10/561,005 →
Publication: US 2008/0138863
Diagnos and Treatment of Fibrosis Related Pathology
Application: 10/562,177 →
Publication: US 2008/0124317
Bone Morphogenetic Protein (Bmp) 2A and Uses Thereof
Application: 10/575,121 →
Publication: US 2008/0249038
Diagnosis and treatment of kidney fibrosis and other fibrotic diseases
Application: 10/579,662 →
Publication: US 2007/0004657
STR50 and uses thereof
Application: 10/612,318 →
Publication: US 2004/0068098
Isocitrate dehydrogenase and uses thereof
Application: 10/618,143 →
Publication: US 2004/0067234
Mitotic kinesin-like protein-1, MKLP1, and uses thereof
Application: 10/671,921 →
Publication: US 2004/0115201
Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
Application: 10/786,830 →
Publication: US 2004/0229886
Gene Identification Method
Application: 11/031,356 →
Publication: US 2005/0272056
Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
Application: 11/045,780 →
Publication: US 2005/0197310
Therapeutic Uses of Inhibitors of RTP801
Patent: 7,741,299 →
Application: 11/207,119 →
Publication: US 2006/0217329
Oligoribonucleotides and Methods of Use Thereof for Treatment of Alopecia, Acute Renal Failure and Other Diseases
Patent: 8,765,699 →
Application: 11/237,598 →
Publication: US 2006/0069056
Annexin II and uses thereof
Application: 11/528,237 →
Publication: US 2007/0098812
Antibody to 5' -Deoxy-5' - Methylthioadenosine And Uses Thereof
Application: 11/547,955 →
Publication: US 2007/0280946
Therapeutic Modulation of the Fas Pathway
Patent: 7,749,977 →
Application: 11/586,021 →
Publication: US 2007/0042418
Therapeutic Uses of Inhibitors of RTP801
Patent: 8,067,570 →
Application: 11/655,636 →
Publication: US 2010/0272722
Novel Tandem Sirnas
Patent: 8,362,229 →
Application: 11/704,600 →
Publication: US 2008/0293655
Methods of preventing or treating brain ischemia or brain injury
Application: 11/705,644 →
Publication: US 2007/0173453
ISLR gene and its association with osteoarthritis and other bone and cartilage disorders, expression products derived therefrom, and uses thereof
Application: 11/807,956 →
Publication: US 2007/0243186
Methods of Treatment of Acute Renal Failure
Patent: 7,842,674 →
Application: 11/827,199 →
Publication: US 2009/0082291
Mitotic kinesin-like protein-1, MKLP1, and uses therof priority
Application: 11/903,942 →
Publication: US 2008/0063638
Therapeutic uses of inhibitors of RTP801
Application: 60/851,000 →
Prevention and treatment of various diseases by inhibition of pro-apoptotic genes
Application: 60/854,503 →
Screening systems utilizing RTP801
Application: 60/855,101 →
Inhibitors of RTP801 and their use in disease treatment
Application: 60/903,737 →
Novel siRNA structures
Application: 60/904,305 →
Oligoribonucleotide inhibitors of Nrf2 and methods of use thereof for treatment of cancer
Application: 60/919,431 →
Methods for treating bone marrow disorders
Application: 60/923,074 →
Therapeutic delivery of inhibitory nucleic acid molecules to the respiratory system
Application: 60/926,559 →
Compositions and methods for inhibiting pro-apoptotic genes
Application: 60/930,493 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 25, 2003
From: FAERMAN, ALEXANDER; KACHALSKY, SYLVIA G.; IDELSON, GREGORY HIRSCH
To: QUARK BIOTECH, INC.
Reel/Frame 014202/0896 →
Assignment of Assignor's Interest Jun 25, 2003
From: QUARK BIOTECH, INC.
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 014202/0894 →
Assignment of Assignor's Interest Oct 29, 2003
From: QUARK BIOTECH, INC.
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 014632/0842 →
Assignment of Assignor's Interest Oct 29, 2003
From: KACHALSKY, SYLVIA G.; FAERMAN, ALEXANDER; PEL-OR, YEHUDA
To: QUARK BIOTECH, INC.
Reel/Frame 014632/0831 →
Assignment of Assignor's Interest Nov 17, 2003
From: EINAT, PAZ; DEISS, LOUIS; MAYA, RUTH
To: QUARK BIOTECH, INC.
Reel/Frame 014695/0623 →
Assignment of Assignor's Interest Apr 30, 2004
From: EINAT, PAZ; DEISS, LOUIS; MAYA, RUTH
To: QUARK BIOTECH, INC.
Reel/Frame 015281/0625 →
Change of Assignees Address Feb 28, 2005
From: QUARK BIOTECH, INC.
To: QUARK BIOTECH, INC.
Reel/Frame 016311/0963 →
Assignment of Assignor's Interest Apr 25, 2005
From: MOR, ORNA; FEINSTEIN, ELENA
To: QUARK BIOTECH, INC.
Reel/Frame 016493/0728 →
Assignment of Assignor's Interest Aug 17, 2005
From: DEISS, LOUIS P.; YEHIELY, FRUMA; EINAT, PAZ
To: QUARK BIOTECH, INC.
Reel/Frame 016894/0732 →
Assignment of Assignor's Interest Nov 16, 2005
From: MOR, ORNA; FEINSTEIN, ELENA; FAERMAN, ALEXANDER
To: QUARK BIOTECH, INC.
Reel/Frame 017933/0360 →
Assignment of Assignor's Interest Dec 5, 2005
From: FEINSTEIN, ELENA
To: QUARK BIOTECH,INC.
Reel/Frame 017315/0483 →
Assignment of Assignor's Interest Dec 9, 2005
From: FEINSTEIN, ELENA; ZURR, DANIEL; EHRLICH, SHAI
To: QUARK BIOTECH, INC.
Reel/Frame 017327/0254 →
Assignment of Assignor's Interest Dec 15, 2005
From: EINAT, PAZ; ZEVIN-SONKIN, DINA; GILAD, SHLOMIT
To: QUARK BIOTECH, INC.
Reel/Frame 017346/0458 →
Assignment of Assignor's Interest Dec 22, 2005
From: MOR, ORNA; FAERMAN, ALEXANDER; FEINSTEIN, ELENA
To: QUARK BIOTECH, INC.
Reel/Frame 017410/0257 →
Assignment of Assignor's Interest Apr 7, 2006
From: FEINSTEIN, ELENA; METT, IGOR; GORODIN, SVETLANA; SHTUTMAN, MICHAEL
To: QUARK BIOTECL, INC.
Reel/Frame 017796/0326 →
Assignment of Assignor's Interest May 17, 2006
From: MOR, ORNA; FEINSTEIN, LENA; SHAPIRA, HAGIT
To: QUARK BIOTECH, INC.
Reel/Frame 017916/0013 →
Assignment of Assignor's Interest Jan 8, 2007
From: FEINSTEIN, ELENA; METT, IGOR; SHTUTMAN, MICHAEL
To: QUARK BIOTECH, INC.
Reel/Frame 018774/0366 →
Merger Jan 22, 2007
From: FUJISAWA PHARMACEUTICAL CO., LTD.
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 018816/0817 →
Assignment of Assignor's Interest Jan 22, 2007
From: QUARK BIOTECH, INC.
To: ATUGEN AG
Reel/Frame 018824/0290 →
Change of Name Jan 22, 2007
From: YAMANOUCHI PHARMACEUTICAL CO., LTD.
To: ASTELLAS PHARMA INC.
Reel/Frame 018816/0853 →
Confirmation of Exclusive Patent License Feb 6, 2007
From: QUARK BIOTECH INC.
To: PFIZER INC.
Reel/Frame 018862/0211 →
Assignment of Assignor's Interest Feb 12, 2007
From: SHIONOGI & CO., LTD.
To: QUARK BIOTECH, INC.
Reel/Frame 018900/0952 →
Assignment of Assignor's Interest Feb 12, 2007
From: NUMATA, YOSHITO; ENOMOTO, KOJI; YAMAUCHI, AKIRA
To: SHIONOGI & CO., LTD.
Reel/Frame 018918/0173 →
Assignment of Assignor's Interest Apr 2, 2007
From: QUARK BIOTECH, INC.
To: ASTELLAS PHARMA INC.
Reel/Frame 019120/0475 →
Assignment of Assignor's Interest Aug 2, 2007
From: FEINSTEIN, ELENA
To: QUARK BIOTECH, INC.
Reel/Frame 019675/0968 →